Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: IRWIN JAMES FRANKEL who wrote (2016)	2/13/2002 10:45:02 PM
From: Cacaito	Respond to of 2515

"Bmy's case was made or lost months ago", Precisely so, the case was MADE months ago, and only a casual look at the dispute with Imcl bias will conclude that Imcl has any chance. Many claim that BMY dd and had access to Fda communications and everything at hand to make an inform decision, BMY does not think so, otherwise Bmy is double stupid to demand anything in public so clearly. Bmy has given plenty of chances to Imcl to solve problems friendly and Imcl has refused. Bmy is given time to the next FDA meeting that will bring a repeat rejection, then all Imcl chances are gone. Imcl mismanagement has caused a year or two of delays in the best case. Imcl waksals past and recent past is full of proven and suspicious misdeeds. It is amazing that the country of the war on drugs is the same accepting a company leader proven cocaine transporter (oh yeah, overturn in technicality) 2 kilograms, thousands are in jail for grams and miligrams and the guy is free after 2 kilograms! Are you choosing Imcl as the right party out of hopeful/grateful shareholder bias? fine. Just plain sympathy for Imcl? fine. Intensive pivotal facts? No way, you do not have any proof about that, you do not know the details of the deal, just the same generalities most know. My opinion is not based in "pivotal facts", it is based on probability that the Imcl guy is clearly on the way of insider trading charges and the behavior of big corporations that will not be bluffing around just to lose. The "analysts" like McCammant that is also a shareholder and his clients portfolio took a margin call recently, and some media calling Bmy poor chances are not neutral parties. The least an investor could do with Imcl is sell to avoid further losses, hold if they are brave believer, buy if very very high casino style risks are in his veins. The signs has been given since the November drops from $70 to $55 with massive distribution cause by sam dumping, oh excuse me, tax related selling need! Or the January FORCED collateral loan related selling!

To: IRWIN JAMES FRANKEL who wrote (2016)	2/13/2002 11:24:50 PM
From: Cacaito	Read Replies (1) \| Respond to of 2515

" The contract allows Bristol-Myers to withdraw if there is a "significant concern regarding a regulatory or patient safety issue that would seriously impact the long-term viability of the product." Above from today New York Times. There are very serious "concerning" issues about the the regulatory process that could impact the long term viability of the product. At the least, Bmy could step out and save $800M, they would still own the 20% of Imcl. But, Bmy wants more, Bmy wants the most they can get. In my view BMY will prevail on their terms.

To: IRWIN JAMES FRANKEL who wrote (2016)	2/14/2002 1:18:09 PM
From: Cacaito	Read Replies (2) \| Respond to of 2515

Case is building up: ""He said ImClone failed to inform Merck in advance of the FDA's rejection, in breach of their agreement, but the company doesn't intend to take legal action yet. "We are worried that the whole mess will have a negative impact on the product getting to market as soon as possible," Scheuble said. Merck sold most of its 3% stake in ImClone via a tender offer and on the stock market late December, he said. "" From detroit4444 yahoo post part 2 of 2. MerckKA sold 3% stake, this # of shares prices from tender (BMY tender?) $70, to mid $60s - mid $50s in December in open markets (guess aproximate) if at average of $60 they got $ millions